Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2017

01-06-2017 | Letter to the Editor

Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma

Authors: Katsuyuki Nishi, Sachiko Mitani, Kazuo Hatanaka, Kazunori Imada

Published in: Annals of Hematology | Issue 6/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413–1420PubMed
2.
3.
4.
5.
6.
Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Müller KG (2012) Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant 47:1020–1029. doi:10.​1038/​bmt.​2011.​161 CrossRefPubMed
7.
8.
Metadata
Title
Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma
Authors
Katsuyuki Nishi
Sachiko Mitani
Kazuo Hatanaka
Kazunori Imada
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2977-y

Other articles of this Issue 6/2017

Annals of Hematology 6/2017 Go to the issue

Letter to the Editor

Bilateral sciatic nerve neurolymphomatosis: PET/CT findings

Original Article

Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β

Letter to the Editor

Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000–2015

Letter to the Editor

Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib

Letter to the Editor

Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major

Original Article

Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits